News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gibson Christopher
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 59,794 shares
@ $7.2085, valued at
$431k
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 10/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 16,913 shares
@ $9.19, valued at
$155.4k
|
|
| 08/11/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 10,000 shares
@ $0
Gifted 10,000 shares
@ $0
Converted 10,000 options to buy
@ $0 |
|
| 08/04/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 60,955 shares
@ $13.0171, valued at
$793.5k
Sold 4,060 shares
@ $13.3631, valued at
$54.3k
Exercised 8,674 options to buy
@ $11.4, valued at
$98.9k
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 10,000 shares
@ $0
Gifted 10,000 shares
@ $0
Converted 10,000 options to buy
@ $0 |
|
| 06/09/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 56,436 shares
@ $9.0511, valued at
$510.8k
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 11,661 shares
@ $5.6, valued at
$65.3k
|
|
| 05/05/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Converted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Converted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Gifted 8,662 shares
@ $0
Converted 1,338 shares
@ $0
Gifted 1,338 shares
@ $0
Sold 33,073 shares
@ $4.7096, valued at
$155.8k
Converted 4,000 shares
@ $0 |
|
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/28/2023 |
4/A
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 3,000 options to buy
@ $0
Converted 18,500 options to buy
@ $0
Converted 12,000 shares
@ $0
Gifted 12,000 shares
@ $0
Converted 12,000 shares
@ $0
Gifted 12,000 shares
@ $0
Converted 12,000 shares
@ $0
Gifted 12,000 shares
@ $0
Converted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Converted 3,000 shares
@ $0 |
|
| 04/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/15/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Converted 3,000 options to buy
@ $0 |
|
| 03/10/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 70,890 shares
@ $8.096, valued at
$573.9k
Gifted 10,000 shares
@ $0
Converted 4,000 shares
@ $0
Sold 4,000 shares
@ $8.0904, valued at
$32.4k
Converted 20,000 shares
@ $0
Sold 20,000 shares
@ $8.095, valued at
$161.9k
Converted 1,000 shares
@ $0
Sold 1,000 shares
@ $8.0867, valued at
$8.1k
Sold 15,000 shares
@ $7.7747, valued at
$116.6k
Exercised 93,750 options to buy
@ $2.48, valued at
$232.5k
Converted 4,000 options to buy
@ $0 |
|
| 03/06/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 18,500 shares
@ $0
Sold 18,500 shares
@ $7.919, valued at
$146.5k
Converted 500 shares
@ $0
Sold 500 shares
@ $7.9041, valued at
$4k
Converted 1,000 shares
@ $0
Sold 1,000 shares
@ $7.9059, valued at
$7.9k
Converted 1,000 shares
@ $0
Sold 1,000 shares
@ $7.9086, valued at
$7.9k
Converted 18,500 options to buy
@ $0
Converted 500 options to buy
@ $0
Converted 1,000 options to buy
@ $0 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Gifted 12,000 shares
@ $0
Gifted 12,000 shares
@ $0
Gifted 12,000 shares
@ $0
Gifted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Converted 18,500 shares
@ $0 |
|
| 12/02/2022 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 18,710 shares
@ $8.7731, valued at
$164.1k
Converted 18,500 shares
@ $0
Sold 18,500 shares
@ $9.2765, valued at
$171.6k
Converted 500 shares
@ $0
Sold 500 shares
@ $9.2648, valued at
$4.6k
Converted 1,000 shares
@ $0
Sold 1,000 shares
@ $9.2773, valued at
$9.3k
Converted 1,000 shares
@ $0
Sold 1,000 shares
@ $9.2773, valued at
$9.3k
Converted 18,500 options to buy
@ $0
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 11/17/2022 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 5,751 shares
@ $11.86, valued at
$68.2k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2022 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 17,553 shares
@ $11.5033, valued at
$201.9k
Converted 18,500 shares
@ $0
Sold 18,500 shares
@ $11.6514, valued at
$215.6k
Converted 500 shares
@ $0
Sold 500 shares
@ $11.6421, valued at
$5.8k
Converted 1,000 shares
@ $0
Sold 1,000 shares
@ $11.6428, valued at
$11.6k
Converted 1,000 shares
@ $0
Sold 1,000 shares
@ $11.6414, valued at
$11.6k
Converted 18,500 options to buy
@ $0
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|